Trial Profile
Serotonin-Transporter Binding in Tourette-Syndrome and Obsessive-Compulsive Disorder before and during Treatment with SRI: a I-123-ADAM-SPECT-Study
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 30 Aug 2013
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Gilles de la Tourette's syndrome; Obsessive-compulsive disorders
- Focus Therapeutic Use
- 30 Aug 2013 New trial record